Found: 14
Select item for more details and to access through your institution.
Vesicle traffic in the outer hair cell.
- Published in:
- European Journal of Neuroscience, 2021, v. 54, n. 3, p. 4755, doi. 10.1111/ejn.15331
- By:
- Publication type:
- Article
Baseline levels of dynamic CD4<sup>+</sup> T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00039
- By:
- Publication type:
- Article
Perforations after routine biopsy in IBD patients, their management and potential risk reductions by microscopic imaging with endocytoscopy.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231218555
- By:
- Publication type:
- Article
I-scan optical enhancement for the in vivo prediction of diminutive colorectal polyp histology: Results from a prospective three-phased multicentre trial.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0197520
- By:
- Publication type:
- Article
Targeting mucosal healing in Crohn's disease: what the clinician needs to know.
- Published in:
- Therapeutic Advances in Gastroenterology, 2019, v. 12, p. N.PAG, doi. 10.1177/1756284819856865
- By:
- Publication type:
- Article
Targeting mucosal healing in Crohn's disease: what the clinician needs to know.
- Published in:
- Therapeutic Advances in Gastroenterology, 2019, v. 12, p. N.PAG, doi. 10.1177/1756284819856865
- By:
- Publication type:
- Article
Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 2, p. 267, doi. 10.1093/ecco-jcc/jjy153
- By:
- Publication type:
- Article
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17703-6
- By:
- Publication type:
- Article
Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn's disease patient upon infliximab-induced lupus-like syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/1756284820982802
- By:
- Publication type:
- Article
Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn's disease patient upon infliximab-induced lupus-like syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/1756284820982802
- By:
- Publication type:
- Article